ERBB2 and breast carcinoma: Since breast cancer is a heterogeneous disease with defined subtypes, we correlated IHC score of C1orf63 to the OS in individual subgroups, namely luminal (Fig. 4A), HER-2 enriched (Fig. 4B), and triple negative breast cancer patients (Fig. 4C), and no significant correlation was found.